ChampionX Reports Third Quarter 2020 Results
10/28/2020
- Revenue of
$633.5 million - Net loss attributable to
ChampionX of$7.9 million ; adjusted net income of$5.5 million - Adjusted EBITDA of
$86.8 million - Cash from operating activities of
$111.4 million and free cash flow of$98.6 million (16% of revenue); free cash flow of$132.0 million excluding$33.4 million of cash payments for transaction and integration expenses - Repaid
$82 million of debt - Increasing our annualized run-rate cost synergies target to
$125 million (versus prior$75 million )
For the third quarter of 2020, revenue was
Results on a pro forma basis for
CEO Commentary
“The health and safety of our employees remains our highest priority, and we continue in our commitment to take all necessary steps to protect them as we navigate through this global pandemic,” ChampionX’s President and Chief Executive Officer Sivasankaran “Soma” Somasundaram said. “I thank all our employees for their continued dedication as they continue to demonstrate outstanding adaptability and flexibility during these uncertain and challenging times. It is a privilege and an honor for me to lead such a high-performing team.”
“The third quarter marked our first full quarter as a new company. Our strong results demonstrate the power of our strengthened portfolio, expanded global scale, as well as meaningful synergy opportunities, all of which we identified as key reasons to bring together our two organizations. While our third quarter pro forma revenue increased a modest 3% sequentially, our adjusted EBITDA of
“Amid this severe industry downturn, we further demonstrated the strong positive free cash flow profile of our company as we generated free cash flow of
“We are proud of how our team is executing on our merger integration plans. Our execution and realization of cost synergies is accelerating and given our progress to date, we now expect to exit 2020 at an annualized run rate of
“Our performance is underpinned by our relentless focus on helping our customers succeed. In the recent supplier performance report on Artificial Lift published by Kimberlite,
“As we look at the fourth quarter, while visibility continues to remain challenging due to the uncertainty caused by the COVID pandemic, combined with seasonal impacts of holidays and year end E&P budget exhaustion, we are encouraged by the stabilization in the price of oil and the October activity so far. On a consolidated basis, in the fourth quarter we expect revenue to be between
“We are even more excited today about the possibilities for our combined company than we were at the closing of the merger. Our disciplined operating model, differentiated products and technology, strong free cash flow, and enhanced production-focused portfolio, combined with a strong and motivated team, will enable us to be a long-term winner in the evolving global oil & gas industry.”
ChampionX Actual Results
Three Months Ended | Variance | |||||||||||||||||
(dollars in thousands, except per share amounts) | 2020 |
2020 |
2019 |
Sequential | Year-over-year | |||||||||||||
Revenue | $ | 633,526 | $ | 298,914 | $ | 276,839 | N/M | N/M | ||||||||||
Net income (loss) attributable to |
$ | (7,914 | ) | $ | (109,645 | ) | $ | 11,394 | N/M | N/M | ||||||||
Diluted earnings (loss) per share attributable to |
$ | (0.04 | ) | $ | (0.95 | ) | $ | 0.15 | N/M | N/M | ||||||||
Adjusted net income (loss) attributable to |
$ | 5,451 | $ | (49,234 | ) | $ | 18,621 | N/M | (71)% | |||||||||
Adjusted diluted earnings (loss) per share attributable to |
$ | 0.03 | $ | (0.43 | ) | $ | 0.24 | N/M | (88)% | |||||||||
Income (loss) before income taxes | $ | (11,294 | ) | $ | (110,001 | ) | $ | 15,013 | N/M | N/M | ||||||||
Income (loss) before income taxes margin | (1.8 | )% | (36.8 | )% | 5.4 | % | N/M | N/M | ||||||||||
Adjusted EBITDA | $ | 86,822 | $ | 34,461 | $ | 63,648 | 152% | 36% | ||||||||||
Adjusted EBITDA margin | 13.7 | % | 11.5 | % | 23.0 | % | 220 bps | (930) bps | ||||||||||
Net cash provided by operating activities | $ | 111,399 | $ | 48,811 | $ | 64,089 | ||||||||||||
Capital expenditures | $ | 12,847 | $ | 11,855 | $ | 8,901 | ||||||||||||
N/M - not meaningful
Third quarter 2020 consolidated revenue includes
Production Chemical Technologies - Actual Results
Three Months Ended | Variance | |||||||||
(dollars in thousands) | 2020 |
2020 |
Sequential | |||||||
Revenue | $ | 410,151 | $ | 136,002 | N/M | |||||
Operating profit | $ | 35,172 | $ | 9,922 | N/M | |||||
Operating profit margin | 8.6 | % | 7.3 | % | 130 bps | |||||
Adjusted segment EBITDA | $ | 71,505 | $ | 22,431 | N/M | |||||
Adjusted segment EBITDA margin | 17.4 | % | 16.5 | % | 90 bps | |||||
Actual results for Production Chemical Technologies for the second quarter of 2020 only includes the month of June, which makes sequential comparisons for the third quarter of 2020 not meaningful.
Production & Automation Technologies - Actual Results
Three Months Ended | Variance | |||||||||||||||||
(dollars in thousands) | 2020 |
2020 |
2019 |
Sequential | Year-over-year | |||||||||||||
Revenue | $ | 136,921 | $ | 114,741 | $ | 221,962 | 19% | (38)% | ||||||||||
Operating profit (loss) | $ | (7,454 | ) | $ | (37,168 | ) | $ | 18,917 | N/M | N/M | ||||||||
Operating profit (loss) margin | (5.4 | )% | (32.4 | )% | 8.5 | % | 2700 bps | (1390) bps | ||||||||||
Adjusted segment EBITDA | $ | 24,995 | $ | 14,492 | $ | 50,462 | 72 | % | (50 | )% | ||||||||
Adjusted segment EBITDA margin | 18.3 | % | 12.6 | % | 22.7 | % | 570 bps | (440) bps | ||||||||||
N/M - not meaningful
In the third quarter of 2020, Production & Automation Technologies revenue increased
Revenue from digital products was
In the third quarter of 2020, segment operating loss was
Drilling Technologies - Actual Results
Three Months Ended | Variance | |||||||||||||||||
(dollars in thousands) | 2020 |
2020 |
2019 |
Sequential | Year-over-year | |||||||||||||
Revenue | $ | 15,715 | $ | 20,948 | $ | 54,877 | (25)% | (71)% | ||||||||||
Operating profit (loss) | $ | (5,127 | ) | $ | (3,811 | ) | $ | 13,797 | N/M | N/M | ||||||||
Operating profit (loss) margin | (32.6 | )% | (18.2 | )% | 25.1 | % | (1440) bps | (5770) bps | ||||||||||
Adjusted segment EBITDA | $ | (2,782 | ) | $ | 1,800 | $ | 16,567 | N/M | N/M | |||||||||
Adjusted segment EBITDA margin | (17.7 | )% | 8.6 | % | 30.2 | % | (2630) bps | (4790) bps | ||||||||||
N/M - not meaningful
In the third quarter of 2020, Drilling Technologies revenue decreased by
Diamond bearings revenue in the third quarter of 2020 was
In the third quarter of 2020, segment operating loss was
Sequentially, the average worldwide and
Reservoir Chemical Technologies - Actual Results
Three Months Ended | Variance | |||||||||
(dollars in thousands) | 2020 |
2020 |
Sequential | |||||||
Revenue | $ | 21,264 | $ | 9,306 | N/M | |||||
Operating loss | $ | (3,819 | ) | $ | (2,811 | ) | N/M | |||
Operating loss margin | (18.0 | )% | (30.2 | )% | 1220 bps | |||||
Adjusted segment EBITDA | $ | (1,432 | ) | $ | (314 | ) | N/M | |||
Adjusted segment EBITDA margin | (6.7 | )% | (3.4 | )% | (330) bps | |||||
Actual results for Reservoir Chemical Technologies for the second quarter of 2020 only includes the month of June, which makes sequential comparisons for third quarter of 2020 not meaningful.
ChampionX Pro Forma Results
Results on a pro forma basis for
Three Months Ended | Variance | |||||||||||||||||
(dollars in thousands, except per share amounts) | 2020 |
2020 |
2019 |
Sequential | Year-over-year | |||||||||||||
Pro forma revenue | $ | 633,526 | $ | 614,684 | $ | 866,506 | 3% | (27)% | ||||||||||
Pro forma net income (loss) attributable to |
$ | 4,667 | $ | (60,100 | ) | $ | 53,251 | N/M | (91)% | |||||||||
Pro forma income (loss) before income taxes | $ | 4,998 | $ | (45,089 | ) | $ | 77,197 | N/M | (94)% | |||||||||
Pro forma Income (loss) before income taxes margin | 0.8 | % | (7.3 | )% | 8.9 | % | 810 bps | (810) bps | ||||||||||
Pro forma adjusted EBITDA | $ | 86,822 | $ | 62,754 | $ | 167,343 | 38% | (48)% | ||||||||||
Pro forma adjusted EBITDA margin | 13.7 | % | 10.2 | % | 19.3 | % | 350 bps | (560) bps | ||||||||||
N/M - not meaningful
Third quarter of 2020 consolidated revenue includes
Revenue for the full third quarter of 2020 was
Production Chemical Technologies - Pro Forma Results
Three Months Ended | Variance | |||||||||||||||||
(dollars in thousands) | 2020 |
2020 |
2019 |
Sequential | Year-over-year | |||||||||||||
Revenue | $ | 410,151 | $ | 433,128 | $ | 514,189 | (5)% | (20)% | ||||||||||
Operating profit | $ | 42,793 | $ | 37,154 | $ | 69,536 | 15% | (38)% | ||||||||||
Operating profit margin | 10.4 | % | 8.6 | % | 13.5 | % | 180 bps | (310) bps | ||||||||||
Adjusted segment EBITDA | $ | 71,505 | $ | 58,466 | $ | 90,953 | 22% | (21)% | ||||||||||
Adjusted segment EBITDA margin | 17.4 | % | 13.5 | % | 17.7 | % | 390 bps | (30) bps | ||||||||||
Results on a pro forma basis for the Production Chemical Technologies segment are provided supplementary to the results of the segment included in the actual results for the Company. See note titled “Results on a Pro Forma Basis” below and the tables included in this release.
Production Chemical Technologies revenue for the full third quarter of 2020 decreased
Operating profit for the full third quarter of 2020 was
Reservoir Chemical Technologies - Pro Forma Results
Three Months Ended | Variance | |||||||||||||||||
(dollars in thousands) | 2020 |
2020 |
2019 |
Sequential | Year-over-year | |||||||||||||
Revenue | $ | 21,264 | $ | 27,950 | $ | 75,441 | (24)% | (72)% | ||||||||||
Operating profit | $ | (3,562 | ) | $ | (16,072 | ) | $ | 3,130 | N/M | N/M | ||||||||
Operating profit margin | (16.8 | )% | (57.5 | )% | 4.1 | % | 4070 bps | (2090) bps | ||||||||||
Adjusted segment EBITDA | $ | (1,432 | ) | $ | (9,573 | ) | $ | 9,657 | N/M | N/M | ||||||||
Adjusted segment EBITDA margin | (6.7 | )% | (34.3 | )% | 12.8 | % | 2760 bps | (1950) bps |
N/M - not meaningful
Results on a pro forma basis for the Reservoir Chemical Technologies segment are provided supplementary to the results of the segment included in the actual results for the Company. See note titled “Results on a Pro Forma Basis” below and the tables included in this release.
Reservoir Chemical Technologies revenue for the full third quarter for 2020 decreased by
For the full third quarter for 2020, segment operating loss was
Other Business Highlights
- In the third quarter,
ChampionX and its employees were actively involved in hurricane relief efforts along theLouisiana andTexas Gulf Coast . - Production Chemical Technologies secured a sole-source contract with a leading E&P operator.
- Production & Automation Technologies secured a multi-year international artificial lift contract, which resulted directly from our Better Together (production chemicals and artificial lift systems) joint sales efforts.
- Our Digital team shipped an order for our Spotlight edge hardware (for monitoring and analysis of online compressors and engines) with a leading E&P operator in
Latin America - Successful Drilling Technologies bearings tests continue for non-oilfield applications (e.g., power generation, industrial mixers, pumps and motors).
- Drilling Technologies has been issued 29 patents year-to-date.
Conference Call Details
To listen to the call via a live webcast, please visit ChampionX’s website at investor.championx.com. The call will also be available by dialing 1-888-424-8151 in
A replay of the conference call will be available on ChampionX’s website or at https://onlineexperiences.com/Launch/QReg/ShowUUID=A91BE40C-0628-492F-9708-DB6FE4F6676D&LangLocaleID=1033. Enter passcode 49983378.
Results on a Pro Forma Basis
On
About Non-GAAP Measures
In addition to financial results determined in accordance with generally accepted accounting principles in
This press release also contains certain forward-looking non-GAAP financial measures, including adjusted EBITDA. Due to the forward-looking nature of the aforementioned non-GAAP financial measure, management cannot reliably or reasonably predict certain of the necessary components of the most directly comparable forward-looking GAAP measures, such as net income. Accordingly, we are unable to present a quantitative reconciliation of such forward looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures. Amounts excluded from these non-GAAP measures in future periods could be significant. Management believes the aforementioned non-GAAP financial measures are good tools for internal use and the investment community in evaluating ChampionX’s overall financial performance.
About
Forward-Looking Statements
This news release contains statements relating to future actions and results, which are "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements relate to, among other things, ChampionX's market position and growth opportunities. Forward-looking statements include, statements related to ChampionX’s expectations regarding the performance of the business, financial results, liquidity and capital resources of
Investor Contact:
byron.pope@championx.com
281-602-0094
Media Contact:
john.breed@championx.com
281-403-5751
i Adjusted net income attributable to
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED)
Three Months Ended | Nine Months Ended | ||||||||||||||||||
(in thousands, except per share amounts) | 2020 | 2020 | 2019 | 2020 | 2019 | ||||||||||||||
Revenue | $ | 633,526 | $ | 298,914 | $ | 276,839 | $ | 1,193,874 | $ | 883,503 | |||||||||
Cost of goods and services | 505,066 | 266,684 | 184,140 | 950,845 | 579,033 | ||||||||||||||
Gross profit | 128,460 | 32,230 | 92,699 | 243,029 | 304,470 | ||||||||||||||
Selling, general and administrative expense | 122,156 | 130,657 | 68,405 | 330,956 | 199,221 | ||||||||||||||
— | — | — | 657,251 | 1,746 | |||||||||||||||
Interest expense, net | 15,935 | 11,262 | 9,590 | 36,236 | 30,226 | ||||||||||||||
Other (income) expense, net | 1,663 | 312 | (309 | ) | 342 | 3,469 | |||||||||||||
Income (loss) before income taxes | (11,294 | ) | (110,001 | ) | 15,013 | (781,756 | ) | 69,808 | |||||||||||
Provision for (benefit from) income taxes | (3,962 | ) | (954 | ) | 3,425 | (31,922 | ) | 15,274 | |||||||||||
Net income (loss) | (7,332 | ) | (109,047 | ) | 11,588 | (749,834 | ) | 54,534 | |||||||||||
Less: Net income attributable to noncontrolling interest | 582 | 598 | 194 | 1,453 | 547 | ||||||||||||||
Net income (loss) attributable to |
$ | (7,914 | ) | $ | (109,645 | ) | $ | 11,394 | $ | (751,287 | ) | $ | 53,987 | ||||||
Earnings (loss) per share attributable to |
|||||||||||||||||||
Basic | $ | (0.04 | ) | $ | (0.95 | ) | $ | 0.15 | $ | (5.73 | ) | $ | 0.70 | ||||||
Diluted | $ | (0.04 | ) | $ | (0.95 | ) | $ | 0.15 | $ | (5.73 | ) | $ | 0.70 | ||||||
Weighted-average shares outstanding: | |||||||||||||||||||
Basic | 199,809 | 115,149 | 77,460 | 131,064 | 77,416 | ||||||||||||||
Diluted | 199,809 | 115,149 | 77,573 | 131,064 | 77,615 | ||||||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)
(in thousands) | |||||||
Assets | |||||||
Cash and cash equivalents | $ | 171,462 | $ | 35,290 | |||
Receivables, net | 516,245 | 219,874 | |||||
Inventories, net | 471,331 | 211,342 | |||||
Prepaid expenses and other current assets | 73,713 | 26,934 | |||||
Total current assets | 1,232,751 | 493,440 | |||||
Property, plant and equipment, net | 868,111 | 248,181 | |||||
660,329 | 911,113 | ||||||
Intangible assets, net | 509,789 | 238,707 | |||||
Other non-current assets | 182,752 | 31,384 | |||||
Total assets | $ | 3,453,732 | $ | 1,922,825 | |||
Liabilities | |||||||
Current portion of long-term debt | $ | 31,470 | $ | 4,845 | |||
Accounts payable | 262,092 | 120,291 | |||||
Other current liabilities | 280,845 | 74,545 | |||||
Total current liabilities | 574,407 | 199,681 | |||||
Long-term debt | 989,690 | 559,821 | |||||
Other long-term liabilities | 303,603 | 127,109 | |||||
Equity | |||||||
Stockholders’ equity | 1,599,549 | 1,032,960 | |||||
Noncontrolling interest | (13,517 | ) | 3,254 | ||||
Total liabilities and equity | $ | 3,453,732 | $ | 1,922,825 | |||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
Nine Months Ended |
|||||||
(in thousands) | 2020 | 2019 | |||||
Cash provided by (used for) operating activities: | |||||||
Net income | $ | (749,834 | ) | $ | 54,534 | ||
Depreciation | 101,434 | 51,126 | |||||
Amortization | 47,827 | 38,504 | |||||
657,251 | 1,746 | ||||||
Receivables | 91,204 | 14,133 | |||||
Inventories | 62,225 | 13,232 | |||||
Accounts payable | (48,519 | ) | (16,861 | ) | |||
Leased assets | (7,799 | ) | (34,305 | ) | |||
Other | 35,643 | 1,281 | |||||
Net cash provided by operating activities | 189,432 | 123,390 | |||||
Cash provided by (used for) investing activities: | |||||||
Capital expenditures | (32,169 | ) | (31,589 | ) | |||
Acquisitions, net of cash acquired | 57,588 | (12,500 | ) | ||||
Proceeds from sale of fixed assets | 9,295 | 2,954 | |||||
Payments on sale of business | — | (2,194 | ) | ||||
Net cash provided by (used for) investing activities | 34,714 | (43,329 | ) | ||||
Cash used for financing activities: | |||||||
Proceeds from long-term debt | 125,000 | 36,500 | |||||
Repayment of long-term debt | (206,713 | ) | (111,500 | ) | |||
Debt issuance costs | (4,356 | ) | — | ||||
Other | (7,376 | ) | (5,949 | ) | |||
Net cash used for financing activities | (93,445 | ) | (80,949 | ) | |||
Effect of exchange rate changes on cash and cash equivalents | 5,471 | (317 | ) | ||||
Net increase (decrease) in cash and cash equivalents | 136,172 | (1,205 | ) | ||||
Cash and cash equivalents at beginning of period | 35,290 | 41,832 | |||||
Cash and cash equivalents at end of period | $ | 171,462 | $ | 40,627 | |||
BUSINESS SEGMENT DATA
(UNAUDITED)
Three Months Ended | Nine Months Ended | ||||||||||||||||||
(in thousands) | 2020 | 2020 | 2019 | 2020 | 2019 | ||||||||||||||
Segment revenue: | |||||||||||||||||||
Production Chemical Technologies | $ | 410,151 | $ | 136,002 | $ | — | $ | 546,153 | $ | — | |||||||||
Production & Automation Technologies | 136,921 | 114,741 | 221,962 | 457,141 | 680,739 | ||||||||||||||
Drilling Technologies | 15,715 | 20,948 | 54,877 | 92,618 | 202,764 | ||||||||||||||
Reservoir Chemical Technologies | 21,264 | 9,306 | — | 30,570 | — | ||||||||||||||
Corporate | 49,475 | 17,917 | — | 67,392 | — | ||||||||||||||
Total revenue | $ | 633,526 | $ | 298,914 | $ | 276,839 | $ | 1,193,874 | $ | 883,503 | |||||||||
Income (loss) before income taxes: | |||||||||||||||||||
Segment operating profit: | |||||||||||||||||||
Production Chemical Technologies | $ | 35,172 | $ | 9,922 | $ | — | $ | 45,094 | $ | — | |||||||||
Production & Automation Technologies | (7,454 | ) | (37,168 | ) | 18,917 | (693,213 | ) | 51,849 | |||||||||||
Drilling Technologies | (5,127 | ) | (3,811 | ) | 13,797 | 2,421 | 64,853 | ||||||||||||
Reservoir Chemical Technologies | (3,819 | ) | (2,811 | ) | — | (6,630 | ) | — | |||||||||||
Total segment operating profit (loss) | 18,772 | (33,868 | ) | 32,714 | (652,328 | ) | 116,702 | ||||||||||||
Corporate expense and other | 14,131 | 64,871 | 8,111 | 93,192 | 16,668 | ||||||||||||||
Interest expense, net | 15,935 | 11,262 | 9,590 | 36,236 | 30,226 | ||||||||||||||
Income (loss) before income taxes | $ | (11,294 | ) | $ | (110,001 | ) | $ | 15,013 | $ | (781,756 | ) | $ | 69,808 | ||||||
Operating profit margin / income (loss) before income taxes margin: | |||||||||||||||||||
Production Chemical Technologies | 8.6 | % | 7.3 | % | — | % | 8.3 | % | — | % | |||||||||
Production & Automation Technologies | (5.4 | )% | (32.4 | )% | 8.5 | % | (151.6 | )% | 7.6 | % | |||||||||
Drilling Technologies | (32.6 | )% | (18.2 | )% | 25.1 | % | 2.6 | % | 32.0 | % | |||||||||
Reservoir Chemical Technologies | (18.0 | )% | (30.2 | )% | — | % | (21.7 | )% | — | % | |||||||||
ChampionX Consolidated | (1.8 | )% | (36.8 | )% | 5.4 | % | (65.5 | )% | 7.9 | % | |||||||||
Adjusted EBITDA | |||||||||||||||||||
Production Chemical Technologies | $ | 71,505 | $ | 22,431 | $ | — | $ | 93,936 | $ | — | |||||||||
Production & Automation Technologies | 24,995 | 14,492 | 50,462 | 79,518 | 144,151 | ||||||||||||||
Drilling Technologies | (2,782 | ) | 1,800 | 16,567 | 14,788 | 72,459 | |||||||||||||
Reservoir Chemical Technologies | (1,432 | ) | (314 | ) | — | (1,746 | ) | — | |||||||||||
Corporate | (5,464 | ) | (3,948 | ) | (3,381 | ) | (11,955 | ) | (10,085 | ) | |||||||||
Adjusted EBITDA | $ | 86,822 | $ | 34,461 | $ | 63,648 | $ | 174,541 | $ | 206,525 | |||||||||
Adjusted EBITDA margin | |||||||||||||||||||
Production Chemical Technologies | 17.4 | % | 16.5 | % | — | % | 17.2 | % | — | % | |||||||||
Production & Automation Technologies | 18.3 | % | 12.6 | % | 22.7 | % | 17.4 | % | 21.2 | % | |||||||||
Drilling Technologies | (17.7 | )% | 8.6 | % | 30.2 | % | 16.0 | % | 35.7 | % | |||||||||
Reservoir Chemical Technologies | (6.7 | )% | (3.4 | )% | — | % | (5.7 | )% | — | % | |||||||||
ChampionX Consolidated | 13.7 | % | 11.5 | % | 23.0 | % | 14.6 | % | 23.4 | % | |||||||||
RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES
(UNAUDITED)
Three Months Ended | Nine Months Ended | ||||||||||||||||||
(in thousands) | 2020 | 2020 | 2019 | 2020 | 2019 | ||||||||||||||
Net income (loss) attributable to |
$ | (7,914 | ) | $ | (109,645 | ) | $ | 11,394 | $ | (751,287 | ) | $ | 53,987 | ||||||
Pre-tax adjustments: | |||||||||||||||||||
— | — | — | 657,251 | 1,746 | |||||||||||||||
Separation and supplemental benefit costs (2) | 383 | (317 | ) | 4,440 | 434 | 6,046 | |||||||||||||
Restructuring and other related charges | 3,426 | 12,128 | 2,720 | 18,320 | 6,751 | ||||||||||||||
Environmental costs | — | — | 1,988 | — | 1,988 | ||||||||||||||
Acquisition and integration related costs (3) | 8,665 | 58,752 | 330 | 78,925 | 330 | ||||||||||||||
Acquisition-related adjustments (4) | 3,511 | 5,831 | — | 9,342 | — | ||||||||||||||
Professional fees related to material weakness remediation and impairment analysis (5) | 940 | 2,044 | — | 5,728 | — | ||||||||||||||
Intellectual property defense | 408 | 181 | — | 800 | — | ||||||||||||||
Tax impact of adjustments (6) | (3,968 | ) | (18,208 | ) | (2,251 | ) | (61,298 | ) | (4,005 | ) | |||||||||
Adjusted net income (loss) attributable to |
5,451 | (49,234 | ) | 18,621 | (41,785 | ) | 66,843 | ||||||||||||
Tax impact of adjustments (6) | 3,968 | 18,208 | 2,251 | 61,298 | 4,005 | ||||||||||||||
Net income attributable to noncontrolling interest | 582 | 598 | 194 | 1,453 | 547 | ||||||||||||||
Depreciation and amortization | 64,848 | 54,581 | 29,567 | 149,261 | 89,630 | ||||||||||||||
Provision for (benefit from) income taxes | (3,962 | ) | (954 | ) | 3,425 | (31,922 | ) | 15,274 | |||||||||||
Interest expense, net | 15,935 | 11,262 | 9,590 | 36,236 | 30,226 | ||||||||||||||
Adjusted EBITDA | $ | 86,822 | $ | 34,461 | $ | 63,648 | $ | 174,541 | $ | 206,525 | |||||||||
Diluted earnings (loss) per share attributable to |
|||||||||||||||||||
Reported | $ | (0.04 | ) | $ | (0.95 | ) | $ | 0.15 | $ | (5.73 | ) | $ | 0.70 | ||||||
Adjusted | $ | 0.03 | $ | (0.43 | ) | $ | 0.24 | $ | (0.32 | ) | $ | 0.86 | |||||||
_______________________
(1) Includes charges for goodwill and long-lived asset impairments of
(2) Separation and supplemental benefit costs primarily relates to separation costs, and to a lesser extent, enhanced or supplemental benefits provided to employees no longer participating in Dover Corporation benefit and compensation plans. Supplemental benefit costs are expected to be incurred through the end of 2020. During the three months ended
(3) Includes costs incurred in relation to business combinations, primarily related to the Merger of legacy
(4) Includes incremental expense related to the step-up of inventory value resulting from the purchase accounting entries. This is partially offset by revenue associated with the amortization of a liability established as part of the Merger, representing unfavorable terms under the Cross Supply Agreement.
(5) Includes professional fees related to the remediation of material weaknesses identified during 2019 as well as professional fees incurred in connection with the goodwill impairment charge recognized during the three months ended
(6) We generally tax effect adjustments using a combined federal and state statutory income tax rate of approximately 23 percent.
Three Months Ended | Nine Months Ended | ||||||||||||||||||
(in thousands) | 2020 | 2020 | 2019 | 2020 | 2019 | ||||||||||||||
Diluted earnings (loss) per share attributable to |
$ | (0.04 | ) | $ | (0.95 | ) | $ | 0.15 | $ | (5.73 | ) | $ | 0.70 | ||||||
Per share adjustments: | |||||||||||||||||||
— | — | — | 5.01 | 0.02 | |||||||||||||||
Separation and supplemental benefit costs | — | — | 0.06 | — | 0.08 | ||||||||||||||
Restructuring and other related charges | 0.02 | 0.11 | 0.04 | 0.14 | 0.09 | ||||||||||||||
Environmental costs | — | — | 0.02 | — | 0.02 | ||||||||||||||
Acquisition and integration related costs | 0.04 | 0.51 | — | 0.60 | — | ||||||||||||||
Acquisition-related adjustments | 0.02 | 0.05 | — | 0.07 | — | ||||||||||||||
Professional fees related to material weakness remediation and impairment analysis | — | 0.01 | — | 0.04 | — | ||||||||||||||
Intellectual property defense | — | — | — | 0.01 | — | ||||||||||||||
Tax impact of adjustments | (0.01 | ) | (0.16 | ) | (0.03 | ) | (0.46 | ) | (0.05 | ) | |||||||||
Adjusted diluted earnings (loss) per share attributable to |
0.03 | (0.43 | ) | 0.24 | (0.32 | ) | 0.86 | ||||||||||||
Free Cash Flow
Three Months Ended | Nine Months Ended | ||||||||||||||||||
(in thousands) | 2020 | 2020 | 2019 | 2020 | 2019 | ||||||||||||||
Free Cash Flow | |||||||||||||||||||
Cash provided by operating activities | $ | 111,399 | $ | 48,811 | $ | 64,089 | $ | 189,432 | $ | 123,390 | |||||||||
Less: Capital expenditures | (12,847 | ) | (11,855 | ) | (8,901 | ) | (32,169 | ) | (31,589 | ) | |||||||||
Free cash flow | $ | 98,552 | $ | 36,956 | $ | 55,188 | $ | 157,263 | $ | 91,801 | |||||||||
Cash transaction expenses | 33,428 | 35,100 | — | 76,244 | — | ||||||||||||||
Adjusted free cash flow | $ | 131,980 | $ | 72,056 | $ | 55,188 | $ | 233,507 | $ | 91,801 | |||||||||
Cash From Operating Activities to Revenue Ratio | |||||||||||||||||||
Cash provided by operating activities | $ | 111,399 | $ | 48,811 | $ | 64,089 | $ | 189,432 | $ | 123,390 | |||||||||
Revenue | $ | 633,526 | $ | 298,914 | $ | 276,839 | $ | 1,193,874 | $ | 883,503 | |||||||||
Cash from operating activities to revenue ratio | 18 | % | 16 | % | 23 | % | 16 | % | 14 | % | |||||||||
Free Cash Flow to Revenue Ratio | |||||||||||||||||||
Free cash flow | $ | 98,552 | $ | 36,956 | $ | 55,188 | $ | 157,263 | $ | 91,801 | |||||||||
Revenue | $ | 633,526 | $ | 298,914 | $ | 276,839 | $ | 1,193,874 | $ | 883,503 | |||||||||
Free cash flow to revenue ratio | 16 | % | 12 | % | 20 | % | 13 | % | 10 | % | |||||||||
PRO FORMA BUSINESS SEGMENT DATA
(UNAUDITED)
Three Months Ended | Nine Months Ended | ||||||||||||||||||
(in thousands) | 2020 | 2020 | 2019 | 2020 | 2019 | ||||||||||||||
Segment revenue: | |||||||||||||||||||
Production Chemical Technologies | $ | 410,151 | $ | 433,128 | $ | 514,189 | $ | 1,353,523 | $ | 1,493,543 | |||||||||
Production & Automation Technologies | 136,921 | 114,741 | 221,962 | 457,141 | 680,739 | ||||||||||||||
Drilling Technologies | 15,715 | 20,948 | 54,877 | 92,618 | 202,764 | ||||||||||||||
Reservoir Chemical Technologies | 21,264 | 27,950 | 75,441 | 98,231 | 256,817 | ||||||||||||||
Corporate | 49,475 | 17,917 | 37 | 67,391 | 146 | ||||||||||||||
Total revenue | $ | 633,526 | $ | 614,684 | $ | 866,506 | $ | 2,068,904 | $ | 2,634,009 | |||||||||
Income (loss) before income taxes: | |||||||||||||||||||
Segment operating profit: | |||||||||||||||||||
Production Chemical Technologies | $ | 42,793 | $ | 37,154 | $ | 69,536 | $ | 150,362 | $ | 166,386 | |||||||||
Production & Automation Technologies | (7,454 | ) | (37,142 | ) | 18,917 | (693,188 | ) | 51,849 | |||||||||||
Drilling Technologies | (5,127 | ) | (3,811 | ) | 13,797 | 2,421 | 64,853 | ||||||||||||
Reservoir Chemical Technologies | (3,562 | ) | (16,072 | ) | 3,130 | (175,098 | ) | 13,726 | |||||||||||
Total segment operating profit (loss) | 26,650 | (19,871 | ) | 105,380 | (715,503 | ) | 296,814 | ||||||||||||
Corporate expense and other | 5,717 | 8,692 | 8,992 | 16,032 | 12,495 | ||||||||||||||
Interest expense, net | 15,935 | 16,526 | 19,191 | 49,939 | 59,597 | ||||||||||||||
Income (loss) before income taxes | $ | 4,998 | $ | (45,089 | ) | $ | 77,197 | $ | (781,474 | ) | $ | 224,722 | |||||||
Operating profit margin / income (loss) before income taxes margin: | |||||||||||||||||||
Production Chemical Technologies | 10.4 | % | 8.6 | % | 13.5 | % | 11.1 | % | 11.1 | % | |||||||||
Production & Automation Technologies | (5.4 | )% | (32.4 | )% | 8.5 | % | (151.6 | )% | 7.6 | % | |||||||||
Drilling Technologies | (32.6 | )% | (18.2 | )% | 25.1 | % | 2.6 | % | 32.0 | % | |||||||||
Reservoir Chemical Technologies | (16.8 | )% | (57.5 | )% | 4.1 | % | (178.3 | )% | 5.3 | % | |||||||||
ChampionX Consolidated | 0.8 | % | (7.3 | )% | 8.9 | % | (37.8 | )% | 8.5 | % | |||||||||
Adjusted EBITDA | |||||||||||||||||||
Production Chemical Technologies | 71,505 | 58,466 | 90,953 | 222,757 | 235,464 | ||||||||||||||
Production & Automation Technologies | 24,995 | 14,493 | 50,462 | 79,518 | 144,151 | ||||||||||||||
Drilling Technologies | (2,782 | ) | 1,800 | 16,567 | 14,788 | 72,459 | |||||||||||||
Reservoir Chemical Technologies | (1,432 | ) | (9,573 | ) | 9,657 | (13,147 | ) | 34,109 | |||||||||||
Corporate | (5,464 | ) | (2,432 | ) | (296 | ) | (8,123 | ) | (677 | ) | |||||||||
Adjusted EBITDA | $ | 86,822 | $ | 62,754 | $ | 167,343 | $ | 295,793 | $ | 485,506 | |||||||||
Adjusted EBITDA margin | |||||||||||||||||||
Production Chemical Technologies | 17.4 | % | 13.5 | % | 17.7 | % | 16.5 | % | 15.8 | % | |||||||||
Production & Automation Technologies | 18.3 | % | 12.6 | % | 22.7 | % | 17.4 | % | 21.2 | % | |||||||||
Drilling Technologies | (17.7 | )% | 8.6 | % | 30.2 | % | 16.0 | % | 35.7 | % | |||||||||
Reservoir Chemical Technologies | (6.7 | )% | (34.3 | )% | 12.8 | % | (13.4 | )% | 13.3 | % | |||||||||
ChampionX Consolidated | 13.7 | % | 10.2 | % | 19.3 | % | 14.3 | % | 18.4 | % | |||||||||
PRO FORMA - RECONCILIATION GAAP TO NON-GAAP FINANCIAL MEASURES
(UNAUDITED)
Three Months Ended | Nine Months Ended | ||||||||||||||||||
(in thousands) | 2020 | 2020 | 2019 | 2020 | 2019 | ||||||||||||||
Net income (loss) attributable to |
$ | 4,667 | $ | (60,100 | ) | $ | 53,251 | $ | (789,858 | ) | $ | 163,130 | |||||||
Pre-tax adjustments: | |||||||||||||||||||
— | — | — | 805,011 | 1,746 | |||||||||||||||
Separation and supplemental benefit costs | 383 | (317 | ) | 4,440 | 434 | 6,046 | |||||||||||||
Restructuring and other related charges | 3,426 | 15,950 | 6,689 | 23,008 | 17,623 | ||||||||||||||
Environmental costs | — | — | 1,988 | — | 1,988 | ||||||||||||||
Acquisition and integration related costs | 250 | 250 | 330 | 884 | 330 | ||||||||||||||
Acquisition-related adjustments | (4,367 | ) | — | — | (4,367 | ) | — | ||||||||||||
Professional fees related to material weakness remediation and impairment analysis | 940 | 2,044 | — | 5,728 | — | ||||||||||||||
Intellectual property defense | 408 | 181 | — | 800 | — | ||||||||||||||
Tax impact of adjustments | (238 | ) | (4,145 | ) | (3,078 | ) | (28,300 | ) | (6,348 | ) | |||||||||
Adjusted net income (loss) attributable to |
5,469 | (46,137 | ) | 63,620 | 13,340 | 184,515 | |||||||||||||
Tax impact of adjustments | 238 | 4,145 | 3,078 | 28,300 | 6,348 | ||||||||||||||
Net income attributable to noncontrolling interest | 582 | (535 | ) | 3,555 | 2,774 | 6,001 | |||||||||||||
Depreciation and amortization | 64,848 | 73,209 | 57,508 | 195,829 | 173,453 | ||||||||||||||
Provision for (benefit from) income taxes | (250 | ) | 15,546 | 20,391 | 5,611 | 55,592 | |||||||||||||
Interest expense, net | 15,935 | 16,526 | 19,191 | 49,939 | 59,597 | ||||||||||||||
Adjusted EBITDA | $ | 86,822 | $ | 62,754 | $ | 167,343 | $ | 295,793 | $ | 485,506 | |||||||||
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES TO PRO FORMA FINANCIAL MEASURES
(UNAUDITED)
Three Months Ended |
|||||||||||
(in thousands, except per share data) | As Reported | Adjustments (1) | Pro Forma | ||||||||
Revenue | $ | 633,526 | $ | — | $ | 633,526 | |||||
Net income (loss) attributable to |
$ | (7,914 | ) | $ | 12,581 | $ | 4,667 | ||||
Pre-tax adjustments: | |||||||||||
Separation and supplemental benefit costs | 383 | — | 383 | ||||||||
Restructuring and other related charges | 3,426 | — | 3,426 | ||||||||
Acquisition and integration related costs | 8,665 | (8,415 | ) | 250 | |||||||
Acquisition-related adjustments | 3,511 | (7,878 | ) | (4,367 | ) | ||||||
Professional fees related to material weakness remediation and impairment analysis | 940 | — | 940 | ||||||||
Intellectual property defense | 408 | — | 408 | ||||||||
Tax impact of adjustments | (3,968 | ) | 3,730 | (238 | ) | ||||||
Adjusted net income (loss) attributable to |
5,451 | 18 | 5,469 | ||||||||
Tax impact of adjustments | 3,968 | (3,730 | ) | 238 | |||||||
Net income attributable to noncontrolling interest | 582 | — | 582 | ||||||||
Depreciation and amortization | 64,848 | — | 64,848 | ||||||||
Provision for (benefit from) income taxes | (3,962 | ) | 3,712 | (250 | ) | ||||||
Interest expense, net | 15,935 | — | 15,935 | ||||||||
Adjusted EBITDA | $ | 86,822 | $ | — | $ | 86,822 | |||||
Three Months Ended |
|||||||||||
(in thousands, except per share data) | As Reported | Adjustments (1) | Pro Forma | ||||||||
Revenue | $ | 298,914 | $ | 315,770 | $ | 614,684 | |||||
Net loss attributable to |
$ | (109,645 | ) | $ | 49,545 | $ | (60,100 | ) | |||
Pre-tax adjustments: | |||||||||||
Separation and supplemental benefit costs | (317 | ) | — | (317 | ) | ||||||
Restructuring and other related charges | 12,128 | 3,822 | 15,950 | ||||||||
Acquisition and integration related costs | 58,752 | (58,502 | ) | 250 | |||||||
Acquisition-related adjustments | 5,831 | (5,831 | ) | — | |||||||
Professional fees related to material weakness remediation and impairment analysis | 2,044 | — | 2,044 | ||||||||
Intellectual property defense | 181 | — | 181 | ||||||||
Tax impact of adjustments | (18,208 | ) | 14,063 | (4,145 | ) | ||||||
Adjusted net income attributable to |
(49,234 | ) | 3,097 | (46,137 | ) | ||||||
Tax impact of adjustments | 18,208 | (14,063 | ) | 4,145 | |||||||
Net income attributable to noncontrolling interest | 598 | (1,133 | ) | (535 | ) | ||||||
Depreciation and amortization | 54,581 | 18,628 | 73,209 | ||||||||
Provision for (benefit from) income taxes | (954 | ) | 16,500 | 15,546 | |||||||
Interest expense, net | 11,262 | 5,264 | 16,526 | ||||||||
Adjusted EBITDA | $ | 34,461 | $ | 28,293 | $ | 62,754 | |||||
Three Months Ended |
|||||||||||
(in thousands, except per share data) | As Reported | Adjustments (1) | Pro Forma | ||||||||
Revenue | $ | 276,839 | $ | 589,667 | $ | 866,506 | |||||
Net income attributable to |
$ | 11,394 | $ | 41,857 | $ | 53,251 | |||||
Pre-tax adjustments: | |||||||||||
Separation and supplemental benefit costs | 4,440 | — | 4,440 | ||||||||
Restructuring and other related charges | 2,720 | 3,969 | 6,689 | ||||||||
Environmental costs | 1,988 | — | 1,988 | ||||||||
Acquisition and integration related costs | 330 | — | 330 | ||||||||
Tax impact of adjustments | (2,251 | ) | (827 | ) | (3,078 | ) | |||||
Adjusted net income attributable to |
18,621 | 44,999 | 63,620 | ||||||||
Tax impact of adjustments | 2,251 | 827 | 3,078 | ||||||||
Net income attributable to noncontrolling interest | 194 | 3,361 | 3,555 | ||||||||
Depreciation and amortization | 29,567 | 27,941 | 57,508 | ||||||||
Provision for income taxes | 3,425 | 16,966 | 20,391 | ||||||||
Interest expense, net | 9,590 | 9,601 | 19,191 | ||||||||
Adjusted EBITDA | $ | 63,648 | $ | 103,695 | $ | 167,343 | |||||
Nine Months Ended |
|||||||||||
(in thousands, except per share data) | As Reported | Adjustments (1) | Pro Forma | ||||||||
Revenue | $ | 1,193,874 | $ | 875,030 | $ | 2,068,904 | |||||
Net loss attributable to |
$ | (751,287 | ) | $ | (38,571 | ) | $ | (789,858 | ) | ||
Pre-tax adjustments: | |||||||||||
657,251 | 147,760 | 805,011 | |||||||||
Separation and supplemental benefit costs | 434 | — | 434 | ||||||||
Restructuring and other related charges | 18,320 | 4,688 | 23,008 | ||||||||
Acquisition and integration related costs | 78,925 | (78,041 | ) | 884 | |||||||
Acquisition-related inventory step-up | 9,342 | (13,709 | ) | (4,367 | ) | ||||||
Professional fees related to material weakness remediation and impairment analysis | 5,728 | — | 5,728 | ||||||||
Intellectual property defense | 800 | — | 800 | ||||||||
Tax impact of adjustments | (61,298 | ) | 32,998 | (28,300 | ) | ||||||
Adjusted net income (loss) attributable to |
(41,785 | ) | 55,125 | 13,340 | |||||||
Tax impact of adjustments | 61,298 | (32,998 | ) | 28,300 | |||||||
Net income attributable to noncontrolling interest | 1,453 | 1,321 | 2,774 | ||||||||
Depreciation and amortization | 149,261 | 46,568 | 195,829 | ||||||||
Provision for (benefit from) income taxes | (31,922 | ) | 37,533 | 5,611 | |||||||
Interest expense, net | 36,236 | 13,703 | 49,939 | ||||||||
Adjusted EBITDA | $ | 174,541 | $ | 121,252 | $ | 295,793 | |||||
Nine Months Ended |
|||||||||||
(in thousands, except per share data) | As Reported | Adjustments (1) | Pro Forma | ||||||||
Revenue | $ | 883,503 | $ | 1,750,506 | $ | 2,634,009 | |||||
Net income attributable to |
$ | 53,987 | $ | 109,143 | $ | 163,130 | |||||
Pre-tax adjustments: | |||||||||||
1,746 | — | 1,746 | |||||||||
Separation and supplemental benefit costs | 6,046 | — | 6,046 | ||||||||
Restructuring and other related charges | 6,751 | 10,872 | 17,623 | ||||||||
Environmental costs | 1,988 | — | 1,988 | ||||||||
Acquisition and integration related costs | 330 | — | 330 | ||||||||
Tax impact of adjustments | (4,005 | ) | (2,343 | ) | (6,348 | ) | |||||
Adjusted net income attributable to |
66,843 | 117,672 | 184,515 | ||||||||
Tax impact of adjustments | 4,005 | 2,343 | 6,348 | ||||||||
Net income attributable to noncontrolling interest | 547 | 5,454 | 6,001 | ||||||||
Depreciation and amortization | 89,630 | 83,823 | 173,453 | ||||||||
Provision for income taxes | 15,274 | 40,318 | 55,592 | ||||||||
Interest expense, net | 30,226 | 29,371 | 59,597 | ||||||||
Adjusted EBITDA | $ | 206,525 | $ | 278,981 | $ | 485,506 | |||||
_______________________
(1) Includes the impact of the historical legacy
Source: ChampionX Corporation